Recombinant Newcastle disease virus (NDV/Anh-IL-2) expressing human IL-2 as a potential candidate for suppresses growth of hepatoma therapy
/in Hepatocellular Carcinoma, International Publications, Newcastle Disease VirusFeasibility study of DCs/CIKs combined with thoracic radiotherapy for patients with locally advanced or metastatic non-small-cell lung cancer
/in Dendritic Cells, International Publications, NSCLCNewcastle disease virus, rituximab, and doxorubicin combination as anti-hematological malignancy therapy
/in International Publications, Newcastle Disease VirusImproving efficacy of hyperthermia in oncology by exploiting biological mechanisms
/in Hyperthermia, International PublicationsDendritic Cell-Based Immunotherapy: State of the Art and Beyond
/in Dendritic Cells, International PublicationsTumor-derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and humans in vitro
/in Exosome, Hepatocellular Carcinoma, International PublicationsT-cell Landscape in a Primary Melanoma Predicts the Survival of Patients with Metastatic Disease after Their Treatment with Dendritic Cell Vaccines
/in Dendritic Cells, International Publications, Malignant MelanomaProspective phase II trial of regional hyperthermia and whole liver irradiation for numerous chemorefractory liver metastases from colorectal cancer
/in Colorectal Cancer, Hyperthermia, International PublicationsEffects of hyperthermia as a mitigation strategy in DNA damage-based cancer therapies
/in Hyperthermia, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer